COVID-19

World first chronic fatigue syndrome findings could fast track response to Long COVID

Study suggests COVID-19 could be a potential trigger for ME/CFS.
Published
Griffith Health

World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms

Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
Published